Rankings
▼
Calendar
VRTX FY 2025 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena
VRTX
Vertex Pharmaceuticals Incorporated
$129B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12.1B
+9.6% YoY
Gross Profit
$10.3B
85.0% margin
Operating Income
$4.8B
39.4% margin
Net Income
$4.0B
32.7% margin
EPS (Diluted)
$15.32
Cash Flow
Operating Cash Flow
$3.6B
Free Cash Flow
$3.2B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$26.1B
Total Liabilities
$7.5B
Stockholders' Equity
$18.7B
Cash & Equivalents
$5.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12.1B
$11.0B
+9.6%
Gross Profit
$10.3B
$9.5B
+8.2%
Operating Income
$4.8B
-$233M
+2144.1%
Net Income
$4.0B
-$536M
+838.1%
← Q4 2024
All Quarters
Q1 2025 →